Efficacy of entecavir monotherapy in nucleoside-naive patients with chronic hepatitis B in a tertiary clinic setting

被引：0
|
作者：
Davison, S. A. [1 ]
Dobbins, T. A. [1 ]
Segaert, N. [1 ]
Koorey, D. J. [1 ]
Shackel, N. A. [1 ]
Bye, W. A. [1 ]
Selby, W. S. [1 ]
McCaughan, G. W. [1 ]
Strasser, S. I. [1 ]
机构：
[1] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW 2050, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A282 / A282
页数：1
相关论文
共 50 条
  • [31] Entecavir is superior to lamivudine for the treatment of HBeAg(+) chronic hepatitis B: results of Phase III study ETV-022 in nucleoside-naive patients
    Chang, TT
    Gish, R
    de Man, R
    Gadano, A
    Sollano, J
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    DeHertogh, D
    Apelian, D
    ANTIVIRAL THERAPY, 2004, 9 (06) : H21 - H22
  • [32] Entecavir maintains high genetic barrier to hepatitis B virus resistance in nucleoside-naive patients through 5 years
    Sievert, W.
    Tenney, D. J.
    Pokornowski, K. A.
    Rose, R. E.
    Baldick, C. J.
    Eggers, B. J.
    Fang, J.
    Yang, J. Y.
    Xu, D.
    Brett-Smith, H.
    Colonno, R. J.
    Slade, P.
    Munafo, L.
    Newman, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A252 - A252
  • [33] FIVE YEARS OF CONTINUOUS ENTECAVIR FOR NUCLEOSIDE-NAiVE HBEAG(+) CHRONIC HEPATITIS B: RESULTS FROM STUDY ETV-901
    Han, Steven-Huy B.
    Chang, Ting-Tsung
    Chao, You-Chen
    Yoon, Seung Kew
    Gish, Robert G.
    Cheinquer, Hugo
    Kitis, George E.
    Zhang, Hui
    Iloeje, Uchenna
    HEPATOLOGY, 2008, 48 (04) : 705A - 706A
  • [34] Efficacy of entecavir in naive patients with chronic hepatitis B and decompensated liver cirrhosis
    Kao, J-T
    Peng, C-Y
    Lai, H-C
    Chuang, P-H
    Su, W-P
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A202 - A202
  • [35] Comparison of the efficacy of entecavir and tenofovir monotherapy for the treatment of treatment - naive patients with hepatitis B virus
    Jung, Young Kul
    Yim, Hyung Joon
    Suh, Sang Jun
    Kwon, Oh Sang
    Kim, Yun Soo
    Choi, Duck Joo
    Kim, Ju H.
    HEPATOLOGY, 2016, 64 : 911A - 911A
  • [36] Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naive adult patients with chronic hepatitis B
    Zhang, T. -T.
    Ye, J.
    Xia, S. -L.
    Zhang, Y. -F.
    Su, Q.
    Zhang, Z. -H.
    Li, X.
    INFECTION, 2013, 41 (02) : 371 - 378
  • [37] Entecavir is superior to lamivudine for the treatment of chronic hepatitis B (CHB): Results of a phase 3 Chinese study (ETV-023) in nucleoside-naive patients
    Yao, G.
    Chen, C.
    Lu, W.
    Ren, H.
    Tan, D.
    Wang, Y.
    Xu, D.
    Jiang, M.
    Liu, J.
    Xu, D.
    MacDonald, L.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S193 - S193
  • [38] Entecavir is well tolerated for the treatment of nucleoside-naive and lamivudine-refractory chronic hepatitis B: Phase 2/3 safety results
    Gish, RG
    Sherman, M
    Lok, AS
    Pockros, PJ
    Raptopoulou-Gigi, M
    Sollano, JD
    Chang, TT
    Cooney, E
    Hindes, RG
    Yang, JY
    Cross, AP
    Wilber, RB
    GASTROENTEROLOGY, 2005, 128 (04) : A693 - A693
  • [39] Entecavir is well tolerated for the treatment of nucleoside-naive and lamivudine-refractory chronic hepatitis B: phase II/III safety results
    Gigi, M. Raptopoulou
    Manns, M.
    Cooney, E.
    Hindes, R.
    Cross, A.
    Wilber, R.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [40] Entecavir is well tolerated for the treatment of nucleoside-naive and lamivudine-refractory chronic hepatitis B: Phase II/II safety results
    Manns, MP
    Raptopoulou-Gigi, M
    Sollano, J
    Gish, RG
    Chang, TT
    Sherman, M
    Yurdaydin, C
    Shouval, D
    Lok, AS
    Cooney, E
    Hindes, R
    Yang, J
    Cross, A
    Wilber, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 185 - 185
12345